THRIVE: Transforming Health: Reclaiming Intrinsic Vitality for Everyone
A Stanford-led coalition won up to $34.5M from ARPA-H to develop the first FDA-grade Intrinsic Capacity Score through the PROSPR program. The initiative aims to produce a regulatory-grade biomarker of physiological resilience and functional aging for use in trials and population health monitoring.
Why it mattersARPA-H granted up to $34.5M to build an FDA-grade Intrinsic Capacity Score under PROSPR.
Entities Mentioned
StanfordFDA